HALO logo
halo search icon
Chemomab Therapeutics Ltd. Sponsored ADR
Chemomab Therapeutics Ltd. Sponsored ADR
CMMB · NAS

Chemomab Therapeutics Ltd. Sponsored ADR

US$1.82

Price Arrow0.16 (9.64%)
21/05/2026 04:00:00 PM
All-ConsensusRecent Price downgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Chemomab Therapeutics Ltd. Sponsored ADR Overview

CMMB Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About CMMB

icon

Telephone

972.77.331.0156

icon

Address

Building 7, Kiryat Atidim, Tel Aviv 6158002

Description

Chemomab Therapeutics Ltd. is a clinical-stage biotech company, which engages in the provision of therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company was founded by Adi Mor on September 22, 2011 and is headquartered in Tel Aviv, Israel.

CMMB Price Chart

Key Stats

Market Cap

US$11.94M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.35 - 5.77

Trade Value (12mth)

US$62,725.00

1 week

0%

1 month

-1.78%

YTD

-7.26%

1 year

-69.49%

All time high

736.00

Key Fundamentals

EPS 3 yr Growth

-85.30%

EBITDA Margin

0.00%

Operating Cashflow

-$11m

Free Cash Flow Return

-86.00%

ROIC

-69.50%

Interest Coverage

0.00

Quick Ratio

9.10

Other Data

Shares Outstanding (Fully Diluted)

8m

HALO Sector

Healthcare

Next Company Report Date

10-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

CMMB Announcements

Latest Announcements

DateAnnouncements
14 May 26
07 May 26
29 April 26
24 March 26
21 March 26

CMMB Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-8.22-3.12-1.42locklocklock
EPS (Fully Diluted)
$locklocklocklock-8.22-3.12-1.42locklocklock
Growth
%locklocklocklock156254.5locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Chemomab Therapeutics Ltd. Sponsored ADR (CMMB:NAS)?
Halo FAQ
The current share price of Chemomab Therapeutics Ltd. Sponsored ADR (CMMB:NAS) is USD$1.82.
What is the 52-week high share price for Chemomab Therapeutics Ltd. Sponsored ADR (CMMB:NAS)?
Halo FAQ
The 52-week high share price for Chemomab Therapeutics Ltd. Sponsored ADR (CMMB:NAS) is USD$5.77.
What is the 52-week low share price for Chemomab Therapeutics Ltd. Sponsored ADR (CMMB:NAS)?
Halo FAQ
The 52-week low share price for Chemomab Therapeutics Ltd. Sponsored ADR (CMMB:NAS) is USD$1.35.
What is the dividend yield for Chemomab Therapeutics Ltd. Sponsored ADR (CMMB:NAS)?
Halo FAQ
Chemomab Therapeutics Ltd. Sponsored ADR (CMMB:NAS) does not pay a dividend.
What was Chemomab Therapeutics Ltd. Sponsored ADR (CMMB:NAS) last dividend payment?
Halo FAQ
Chemomab Therapeutics Ltd. Sponsored ADR (CMMB:NAS) does not pay a dividend.
What is the franking level for Chemomab Therapeutics Ltd. Sponsored ADR (CMMB:NAS)?
Halo FAQ
Chemomab Therapeutics Ltd. Sponsored ADR (CMMB:NAS) has a franking level of 0.00%.
In which sector is Chemomab Therapeutics Ltd. Sponsored ADR (CMMB:NAS) classified?
Halo FAQ
Chemomab Therapeutics Ltd. Sponsored ADR (CMMB:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.